Close X
Tuesday, December 3, 2024
ADVT 
International

Jack Dorsey quits as Twitter CEO, announces IIT man Parag Agrawal as successor

Darpan News Desk IANS, 29 Nov, 2021 11:48 AM
  • Jack Dorsey quits as Twitter CEO, announces IIT man Parag Agrawal as successor

Agrawal, CTO since 2017, isn't in for an easy time. Twitter's stated goal of monetisation for one - 315 million monetisable daily active users by the end of 2023 and doubling of annual revenue. Agrawal's specialisation has been strategy involving artificial intelligence and machine learning (read: no finance as yet).

Before studying computer science at IIT, he attended the Atomic Energy Kendriya Vidyalaya.

While studying at Stanford, Agrawal worked as a research intern for Microsoft, Yahoo!, and AT&T Labs.

After graduating from Stanford, he joined Twitter as an ads engineer. He served in that position from October 2011 to October 2017.

His early work as CTO was dedicated to increasing the relevance of tweets in Twitter timelines through the use of artificial intelligence.

Dorsey's exit isn't a surprise. He was under pressure from activist investor Elliott Management Corp, even over how he was spending his time. A year earlier, Dorsey had said he planned to spend up to six months of the year working in Africa to better understand the continent's internet users, a move that was ultimately scrapped due to Covid-19.

The hedge fund reached an agreement with Twitter and private equity group Silver Lake to appoint three new Directors to Twitter's board and create a committee to review leadership and governance. The deal came at a cost. Dorsey was expected to grow Twitter's monetised daily users by 20 per cent or more and boost revenue growth.

Agrawal's remarkable journey starts from a Kendriya Vidyalaya under the Atomic Energy Education Society (AEES), set up for education to children of the employees of the Department of Atomic Energy and its constituent units. From one school in Anushaktinagar, Mumbai in 1969, AEES administers 30 schools and junior colleges at 16 locations all over the country.

MORE International ARTICLES

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK